Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
3 Biotech Stocks to Buy and Hold for the Next 10 Years
08:50am, Monday, 26'th Feb 2024
CRISPR Therapeutics' recent major regulatory win could be the first of many. Axsome Therapeutics should ride the wave from its rich late-stage pipeline.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 23'rd Feb 2024
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Amgen Inc. (AMGN) Amgen Meeting on Rare Disease (Transcript)
09:53pm, Thursday, 22'nd Feb 2024
Amgen Inc. (NASDAQ:AMGN) Amgen Meeting on Rare Disease February 22, 2024 4:00 PM ET
AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
04:00pm, Monday, 19'th Feb 2024
THOUSAND OAKS, Calif. , Feb. 19, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call at 1:00 p.m.
Where Are Biotech ETFs Headed After Q4 Earnings?
05:51pm, Wednesday, 14'th Feb 2024
Look into how Biotech ETFs performed after Q4 earnings.
Amgen Inc. (AMGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)
03:36pm, Wednesday, 14'th Feb 2024
Amgen Inc. (AMGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
02:43pm, Wednesday, 14'th Feb 2024
It is entirely fair to state that weight loss treatments have massive transformational power. US FDA approval of weight loss medicines could help shrink millions of waistlines.
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
02:59am, Wednesday, 14'th Feb 2024
Amgen is the latest big pharma to join the gold rush to treat obesity. Its candidate is distinct from the medicines by Eli Lilly and Novo Nordisk.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Monday, 12'th Feb 2024
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
04:00pm, Friday, 09'th Feb 2024
THOUSAND OAKS, Calif. , Feb. 9, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 34th Annual Oppenheimer Healthcare Life Sciences Conference at 12:00 p.m.
PBYI vs. AMGN: Which Stock Should Value Investors Buy Now?
12:40pm, Friday, 09'th Feb 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Puma Biotech (PBYI) and Amgen (AMGN). But which of these two stocks offers value investors a better
Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz
06:24pm, Thursday, 08'th Feb 2024
Jared Holz, Mizuho, joins 'Closing Bell Overtime' to talk Amgen's obesity drug trial results.
Amgen (AMGN) Q4 Earnings Top, Horizon Drugs Drive Sales
10:56am, Wednesday, 07'th Feb 2024
Amgen (AMGN) beats fourth-quarter estimates for earnings and sales. Horizon's products add $954 million in sales in the quarter.
Amgen Inc. (AMGN) Q4 2023 Earnings Call Transcript
10:40pm, Tuesday, 06'th Feb 2024
Amgen Inc. (AMGN) Q4 2023 Earnings Call Transcript
Amgen (AMGN) Reports Q4 Earnings: What Key Metrics Have to Say
09:01pm, Tuesday, 06'th Feb 2024
Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street
